CATALOGO DEI PRODOTTI DELLA RICERCA

ROSSINI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.349
NA - Nord America 13.973
AS - Asia 9.189
SA - Sud America 1.150
AF - Africa 100
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 16
Totale 38.806
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.855
GB - Regno Unito 5.140
CN - Cina 3.592
SG - Singapore 3.402
IT - Italia 1.868
RU - Federazione Russa 1.282
HK - Hong Kong 1.183
FR - Francia 1.179
DE - Germania 1.166
SE - Svezia 1.076
IE - Irlanda 1.041
BR - Brasile 1.023
FI - Finlandia 830
UA - Ucraina 289
KR - Corea 242
TR - Turchia 178
IN - India 153
JP - Giappone 113
NL - Olanda 111
VN - Vietnam 80
BE - Belgio 72
CA - Canada 72
AT - Austria 59
ES - Italia 49
TG - Togo 42
RO - Romania 39
IQ - Iraq 38
IR - Iran 31
AR - Argentina 29
PL - Polonia 29
BD - Bangladesh 28
EC - Ecuador 28
ID - Indonesia 27
AU - Australia 25
MX - Messico 23
ZA - Sudafrica 22
UZ - Uzbekistan 20
CL - Cile 18
VE - Venezuela 18
NP - Nepal 16
CH - Svizzera 14
CO - Colombia 14
CZ - Repubblica Ceca 14
GR - Grecia 12
MA - Marocco 12
PT - Portogallo 12
EG - Egitto 9
SK - Slovacchia (Repubblica Slovacca) 9
EU - Europa 8
IL - Israele 8
PK - Pakistan 8
BG - Bulgaria 7
BO - Bolivia 7
HR - Croazia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AZ - Azerbaigian 6
JO - Giordania 6
KG - Kirghizistan 6
SA - Arabia Saudita 6
DK - Danimarca 5
KW - Kuwait 5
LT - Lituania 5
PE - Perù 5
QA - Qatar 5
AL - Albania 4
DZ - Algeria 4
HN - Honduras 4
JM - Giamaica 4
KE - Kenya 4
LK - Sri Lanka 4
LV - Lettonia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
BY - Bielorussia 3
CR - Costa Rica 3
EE - Estonia 3
HU - Ungheria 3
MK - Macedonia 3
MY - Malesia 3
PH - Filippine 3
SI - Slovenia 3
SV - El Salvador 3
TH - Thailandia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
IS - Islanda 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
Totale 38.787
Salva come PNG Salva come JPEG
Città #
Southend 4.776
Jacksonville 2.236
Chandler 2.205
Singapore 2.088
Woodbridge 1.234
Hong Kong 1.166
Dublin 1.025
Ann Arbor 959
Ashburn 722
Houston 672
Beijing 577
Lawrence 447
Princeton 447
Wilmington 423
Jinan 327
Nanjing 295
Shenyang 279
New York 262
Verona 239
Redmond 238
Bologna 207
Helsinki 197
Milan 179
Sindelfingen 178
Hebei 175
The Dalles 149
Tianjin 146
Changsha 132
Ningbo 113
Haikou 109
Nanchang 107
Boardman 106
Zhengzhou 105
Tokyo 98
Jiaxing 88
Hangzhou 83
Taizhou 83
Los Angeles 79
Rome 76
São Paulo 76
Seattle 74
Dallas 73
Redwood City 72
Guangzhou 68
Taiyuan 68
Brussels 65
Norwalk 65
Santa Clara 61
Munich 57
Washington 57
San Francisco 56
Moscow 52
Falls Church 51
Fairfield 48
Hyderabad 45
Turku 44
Dearborn 42
Fuzhou 42
Lanzhou 42
Lomé 42
Dong Ket 41
Vienna 41
Orani 40
Chicago 38
Belo Horizonte 31
Rio de Janeiro 31
Düsseldorf 30
Toronto 30
Amsterdam 28
Seoul 27
Groningen 26
London 26
Nuremberg 26
Dongguan 25
Brasília 24
Cagliari 24
Detroit 24
Jakarta 24
Brooklyn 22
Lancaster 22
Frankfurt am Main 21
Warsaw 21
Sanayi 20
Tashkent 19
Curitiba 18
Lappeenranta 18
Nürnberg 18
Venice 18
Kent 17
Paris 17
Esslingen am Neckar 16
Menlo Park 16
Torino 16
Campinas 15
Council Bluffs 15
Porto Alegre 15
Atlanta 14
Brescia 14
Padova 14
Phoenix 14
Totale 25.143
Salva come PNG Salva come JPEG
Nome #
Fibromialgia. Razionale e risultati del trattamento con L-Acetilcarnitina. 384
Epidemiology and Economic Burden of Osteoporosis in Italy 336
Teriparatide and denosumab combination therapy and skeletal metabolism 257
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 239
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 194
Artrite Reumatoide e Metabolismo Minerale 185
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 166
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 166
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 163
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 162
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 162
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 159
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 150
The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes 146
Incidenza di ipovitaminosi D nel Nord Italia 144
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 143
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 142
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 137
[Therapeutic strategies in osteoporosis: whom and when to treat] 136
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 135
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 135
Age-related bone loss in postmenopausal women 134
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 134
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 134
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 133
DXA bone mineral density in males: retrospective study in real life. 132
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 132
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 132
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 131
Rapporti tra sistema immune e metabolismo osseo 129
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 129
Prevalence and incidence of rheumatoid arthritis in Italy. 127
Bone metabolism in patients with anorexia nervosa and amenorrhoea 127
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 126
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 125
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 125
Anti-CCP antibodies and bone 124
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 123
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 123
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 122
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 122
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 121
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 120
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 120
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 119
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 118
Guidelines for the diagnosis, prevention and management of osteoporosis 118
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 118
Osteoporosis treatment: why ibandronic acid? 116
Safety issues and adverse reactions with osteoporosis management 115
The renal handling of calcium: influence of parathyroid hormone secretion 114
Vitamin D levels in patients with psoriasis with or without arthritis 114
Prevalence of osteoporosis in patients affected by mastocytosis 114
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 114
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 113
Incidenza di ipovitaminosi D nel Nord Italia 112
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 112
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 112
[Risk factors for hip fracture in elderly persons]. 112
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 112
Osteopetrosi 111
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 111
Anabolic steroids in corticosteroid-induced osteoporosis 110
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 110
Osteoporosi: progressi nella diagnosi e nel trattamento 110
Bone involvement in patient with clonal mast cell disorders 110
Bone turnover markers in patients with osteogenesis imperfecta. 109
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 109
Could γ\δ T-cells explain zoledronic acid adverse events? 109
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 108
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 108
Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH Agonist. 108
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 107
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 107
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 107
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 107
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 107
Bone involvement and osteoporosis in mastocytosis. 106
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 105
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 105
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 105
Duration of treatment for osteoporosis 104
Effects of denosumab on peripheral lymphocyte subpopulations 104
The radiological assessment of vertebral osteoporosis 103
Bone turnover markers in patients with osteogenesis imperfecta 103
the use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemnia of malignanacy 103
Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis. 103
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 103
The initiative on hip fractures of the Veneto Region 103
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 103
Osteoporisis costs in Italy: interim results of the block study 102
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 102
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. 101
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 101
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 101
Peak bone mass and peak bone density. 101
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 100
Sclerostin and DKK1 in primary hyperparathyroidism. 100
Drug-induced osteonecrosis of the jaw: the state of the art 100
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 100
Totale 12.805
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.499
article - articoli 142.987
book - libri 0
conference - conferenze 2.157
curatela - curatele 0
other - altro 311
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.044
Totale 298.998
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020473 0 0 0 0 0 0 0 0 0 0 0 473
2020/20213.874 425 727 112 434 496 425 82 242 306 27 440 158
2021/20223.269 238 807 49 158 155 128 61 185 278 97 305 808
2022/20236.835 560 555 703 1.180 607 1.652 86 384 732 75 226 75
2023/20243.514 179 270 330 418 403 534 180 274 58 128 494 246
2024/20259.348 564 679 406 1.475 472 257 444 469 1.414 810 701 1.657
Totale 39.570